Marcy Graham - Aadi Bioscience SVP Communications
| AADIDelisted Stock | USD 2.05 0.05 2.38% |
Insider
Marcy Graham is SVP Communications of Aadi Bioscience
| Age | 57 |
| Phone | 424 744 8055 |
| Web | https://aadibio.com |
Aadi Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6595) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Erick MD | Acrivon Therapeutics, Common | 67 | |
| Kristina Masson | Acrivon Therapeutics, Common | 44 | |
| Jeff Knight | Crinetics Pharmaceuticals | 54 | |
| Kevin Capps | Crinetics Pharmaceuticals | N/A | |
| David Pompliano | Revolution Medicines | N/A | |
| Michael Alley | AN2 Therapeutics | N/A | |
| Esq JD | Kura Oncology | 58 | |
| MD FACP | AN2 Therapeutics | 77 | |
| Camille MD | Ultragenyx | 71 | |
| Margaret JD | Revolution Medicines | 62 | |
| Brian MD | Rezolute | 50 | |
| John II | Ultragenyx | 59 | |
| Ajim CFA | Monte Rosa Therapeutics | 47 | |
| Benjamin Dake | Aerovate Therapeutics | 49 | |
| JD MBA | Monte Rosa Therapeutics | 46 | |
| Joseph Zakrzewski | AN2 Therapeutics | 63 | |
| Adriana MBA | Crinetics Pharmaceuticals | N/A | |
| Donna Dea | Aerovate Therapeutics | N/A | |
| John Castle | Monte Rosa Therapeutics | 54 | |
| Silvia Buonamici | Monte Rosa Therapeutics | N/A | |
| Stephen MD | Kura Oncology | 53 | |
Management Performance
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 |
Aadi Bioscience Leadership Team
Elected by the shareholders, the Aadi Bioscience's board of directors comprises two types of representatives: Aadi Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aadi. The board's role is to monitor Aadi Bioscience's management team and ensure that shareholders' interests are well served. Aadi Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aadi Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Desai, President, Founder | ||
| Raymond Steitz, Senior Officer | ||
| Bryan Ball, Chief Operations | ||
| David Lennon, CEO President | ||
| Marcy Graham, SVP Communications | ||
| Stephen JD, Senior Counsel | ||
| Brendan MBA, Chief Officer | ||
| David Dornan, Chief Officer | ||
| MD FACP, Chief Officer | ||
| Scott CPA, Treasurer, CFO |
Aadi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aadi Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.49) % | ||||
| Current Valuation | 35.53 M | ||||
| Shares Outstanding | 46.29 M | ||||
| Shares Owned By Insiders | 6.09 % | ||||
| Shares Owned By Institutions | 50.02 % | ||||
| Number Of Shares Shorted | 764.36 K | ||||
| Price To Book | 1.41 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Aadi Stock
If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |